1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 26,000 | 27,600 | 12.05. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.03. | BASTIDE: 2025-2026 half-year results | 962 | Actusnews Wire | Recurring operating margin: 9.0%, in line with the annual target
Operating profit up 12.5%
Operating free cash flow: €24.3 million, a threefold increase in one year
Significant improvement... ► Artikel lesen | |
| 12.02. | BASTIDE: Organic growth of 8.2% in first-half 2025-2026: Confirmed excellent growth momentum in home healthcare services: 9.2% / Accelerated growth in the Homecare business, up 6.5% // 2025-2026 targets confirmed | 445 | Actusnews Wire | Caissargues, February 12, 2026 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-half 2025-2026, ending December 31, 2025.
In... ► Artikel lesen | |
| 13.11.25 | BASTIDE: Organic growth of 8.3% in first-quarter 2025-2026: Sustained growth in home healthcare services, up 10.7% / Homecare business up 4.7%, driven by the healthcare institutions business (up 8.5%) | 513 | Actusnews Wire | Caissargues, November 13, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has published its revenue for first-quarter 2025-2026, ending September 30, 2025.
In... ► Artikel lesen | |
| 28.10.25 | BASTIDE: 2025-2026 financial calendar | 1.039 | Actusnews Wire | Caissargues, October 28, 2025
Events
Dates*
2025-2026 Q1 Revenue
Thursday November 13, 2025
2025-2026 H1 Revenue
Thursday February 12, 2026
2025-2026 H1 Results
Wednesday... ► Artikel lesen | |
| 22.10.25 | BASTIDE: 2024-2025 annual results in line with targets // 2025-26 outlook: Revenue of over EUR 510 million and recurring operating margin around 9%, Leverage of less than 3x and decrease in financial expenses | 868 | Actusnews Wire | Caissargues, October 22, 2025 - Groupe Bastide, a leading European provider of home healthcare services, has announced its 2024-2025 annual results at June 30, 2025. The 2024-2025 annual consolidated... ► Artikel lesen | |
| 24.09.25 | BASTIDE: Groupe Bastide completes the sale of Baywater Healthcare to Sapio Group | 797 | Actusnews Wire | Caissargues, September 24, 2025
In line with the timetable set out in its 30 June 2025 communication announcing the agreement to sell Baywater Healthcare, a leading player in the UK respiratory... ► Artikel lesen | |
| 04.09.25 | BASTIDE: 2024-2025 revenue target met // 2024-2025 revenue from continuing operations: EUR 491 million, up 8% ( EUR 561 million, excluding impact of disposals) | 585 | Actusnews Wire | Caissargues, September 4, 2025
Groupe Bastide has published its annual revenue for 2024-2025. In accordance with IFRS 5, reported revenue relates exclusively to continuing operations, and no... ► Artikel lesen | |
| BASTIDE LE CONFORT MEDICAL Aktie jetzt für 0€ handeln | |||||
| 30.06.25 | BASTIDE: Bastide Groupe Sells Baywater Healthcare To Sapio Group | 752 | Actusnews Wire | Crewe, United Kingdom & Monza, Italy - 30th June 2025
Bastide le Confort Medical SA (hereinafter "Groupe Bastide") today announced that it has agreed to the sale of its subsidiary Baywater Healthcare... ► Artikel lesen | |
| 09.06.25 | BASTIDE: Disposal of CICADUM and MEDSOFT | 626 | Actusnews Wire | Caissargues, June 9, 2025
Bastide Groupe announced today the disposal of its French subsidiaries, Cicadum, 51%-owned, (signing subject to financing condition precedent) and Medsoft, 100%-owned... ► Artikel lesen | |
| 05.06.25 | BASTIDE: Disposal of DORGE and DYNA MEDICAL in Belgium | 600 | Actusnews Wire | Caissargues, June 5, 2025
Bastide Groupe announced today the disposal of its Belgian subsidiaries, Dorge Medic, which specializes in the sale and rental of medical equipment and products for... ► Artikel lesen | |
| 04.06.25 | BASTIDE: Respiratory care therapy: Baywater wins London region tender and consolidates its leading position in the UK | 553 | Actusnews Wire | Caissargues, June 4, 2025
After being chosen one year ago by the National Health Service (NHS) to be the exclusive operator for respiratory care (oxygen therapy) in the East of England region... ► Artikel lesen | |
| 15.05.25 | BASTIDE: Continued strong organic growth in Q3 2024-2025 at +7.7%: Home healthcare services up 10.4% and recovery of Homecare activities confirmed / 2024-2025 targets confirmed | 543 | Actusnews Wire | Caissargues, May 15, 2025
In € millions
2023-2024
published
2023-2024*
Adjusted
2024-2025
published
Change
First-quarter revenue
127.9
122.7
133.8
+9.1%
Second-quarter... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ANSELL | 15,600 | -2,50 % | ANSELL LIMITED: Becoming a substantial holder | ||
| AMBEA | 13,520 | -0,66 % | Ambea AB: Report from Ambea's Annual General Meeting 12 May 2026 | Today's Annual General Meeting in Ambea AB (publ) voted to support the following proposals from the board of directors and the nomination committee.
The Annual General Meeting adopted the annual report... ► Artikel lesen | |
| FRESENIUS | 39,520 | -0,90 % | EQS-News: Fresenius SE & Co. KGaA: Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt (News... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 33,900 | +0,98 % | Siemens Healthineers: Aktie rutscht nach enttäuschenden Zahlen ab - Anleger reagieren enttäuscht | Schwache Quartalszahlen und anhaltende Probleme in China setzen Siemens Healthineers weiter unter Druck. Die Aktie verliert deutlich, während der Medizintechnikkonzern seine Prognose für das laufende... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,660 | +1,05 % | Fresenius Medical Care: Anleger bleiben trotz Sparkurs skeptisch | Trotz eines überraschend stabilen operativen Ergebnisses rutscht die Aktie nach Vorlage der Quartalszahlen deutlich ab. Wechselkurse und hohe Kosten setzen dem Konzern weiter zu, während das Management... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP | 7,330 | 0,00 % | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | ||
| GERRESHEIMER | 28,400 | +1,21 % | EQS-DD: Gerresheimer AG: AOC Gecko S.à r.l., Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.05.2026 / 17:10... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,370 | +7,05 % | S&P Dow Jones Indices: Alignment Healthcare Set to Join S&P SmallCap 600 | NEW YORK, May 11, 2026 /PRNewswire/ -- Alignment Healthcare Inc. (NASD: ALHC) will replace Sun Country Airlines Holdings Inc. (NASD: SNCY) in the S&P SmallCap 600... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 55,48 | +0,74 % | Recent Price Trend in BrightSpring Health Services, Inc. (BTSG) is Your Friend, Here's Why | ||
| HIMS & HERS HEALTH | 21,380 | -13,65 % | Earnings Preview: Nebius, Hims & Hers, Cisco & Co. Welche Zahlen diese Woche spannend werden! | © Foto: Yuki Iwamura - AP/dpa +++ dpa-Bildfunk +++Diese in den kommenden Tagen (KW20) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,730 | +8,62 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,940 | +3,52 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| PACS GROUP | 41,030 | +28,62 % | PACS Group hebt Prognose an - Aktie legt nach Quartalszahlen um 16 % zu | ||
| PROGYNY | 23,460 | 0,00 % | 3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY |
Das Unternehmen BASTIDE LE CONFORT MEDICAL SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 26,450 Euro und damit -0,38 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BASTIDE LE CONFORT MEDICAL SA finden Sie auf Wallstreet Online.